Cite
EXO1 overexpression is associated with poor prognosis of hepatocellular carcinoma patients.
MLA
Dai, Yaoyao, et al. “EXO1 Overexpression Is Associated with Poor Prognosis of Hepatocellular Carcinoma Patients.” Cell Cycle, vol. 17, no. 19/20, Oct. 2018, pp. 2386–97. EBSCOhost, https://doi.org/10.1080/15384101.2018.1534511.
APA
Dai, Y., Tang, Z., Yang, Z., Zhang, L., Deng, Q., Zhang, X., Yu, Y., Liu, X., & Zhu, J. (2018). EXO1 overexpression is associated with poor prognosis of hepatocellular carcinoma patients. Cell Cycle, 17(19/20), 2386–2397. https://doi.org/10.1080/15384101.2018.1534511
Chicago
Dai, Yaoyao, Zuxiong Tang, Zongguo Yang, Lan Zhang, Qing Deng, Xiaofeng Zhang, Yongchun Yu, Xing Liu, and Junfeng Zhu. 2018. “EXO1 Overexpression Is Associated with Poor Prognosis of Hepatocellular Carcinoma Patients.” Cell Cycle 17 (19/20): 2386–97. doi:10.1080/15384101.2018.1534511.